The sialyl Lewis a and x (sLe a/x ) antigens frequently displayed on the surface of tumor cells are involved in metastasis. Their synthesis has been attributed to altered expression of selective glycosyltransferases. Identification of these glycosyltransferases and the glycoproteins that carry these carbohydrate antigens should help advance our understanding of selectin-mediated cancer metastasis. In this study, quantitative real-time polymerase chain reaction analysis coupled with in situ proximity ligation assay and small interference RNA treatment shows involvement of β3galactosyl-transferase-V in the synthesis of MUC16-associated sLe a in H292 cells. Also, α3fucosyltransferase-V, which is absent in BEAS-2B human immortalized bronchial epithelial cells and A549 lung carcinoma cells, participates in the synthesis of MUC1-associated sLe x in CFT1 human immortalized bronchial epithelial cells and H292 lung carcinoma cells. Neither selectin ligand is found on MUC1 in BEAS-2B and A549 cells. Knockdown of either enzyme suppresses migration, and selectin tethering and rolling properties of H292 cells under dynamic flow as determined by wound healing and parallel plate flow chamber assays, respectively. These results provide insights into how the synthesis of mucinassociated selectin ligands and the metastatic properties of cancer cells can be regulated by selective glycosyltransferases that work on mucins. They may help develop novel anticancer drugs.
Introduction
Around 90% of cancer deaths are caused by tumor metastasis. Metastatic cancer cells employ the trafficking mechanisms utilized by leukocytes to target distant sites (Laubli and Borsig 2010) . Following dissemination from the primary tumor into the blood stream, the circulating cancer cells are tethered to and roll on the endothelium at distant sites to establish firm adhesion prior to extravasation (Chambers et al. 2001 ). Tethering and rolling are mediated by interaction of selectins with their cognate carbohydrate ligands, Sialyl Lewis a (sLe a ) and sialyl Lewis × (sLe et al. 2013) . Biosynthesis of sLe a or sLe x (Figure 1 ) is initiated by addition of Gal in a β1,3 or β1,4 linkage, respectively, to a N-acetylglucosamine (GlcNAc) residue at the non-reducing terminus of an oligosaccharide chain. The structures of these two glycan products, which are designated as type-1 and type-2 lactosamine chains, are generated by β3GalT and β4GalT enzymes, respectively. Then, sialic acid is added to the Gal residue in an α2,3 linkage as catalyzed by ST3Gal (Ellies et al. 2002) . Finally, fucose is added to the GlcNAc residue in an α1,3/1,4 linkage to complete the synthesis of these glycans (Brockhausen 2006) . The isozymes within these four groups of glycosyltransferases (GTs) involved in the synthesis of these two sialyl Lewis antigens are: β3GalT-I, II and V (Hennet et al. 1998; Isshiki et al. 1999) , β4GalT-I, II, IV and V (Hennet 2002) , ST3Gal-III, IV and VI (Ellies et al. 2002) and α3/4FucT-III-VII (de Vries et al. 1995; Oriol et al. 1999; Norden et al. 2009 ). One major limitation in this area of glycobiology is a lack of a clear understanding of specific GT isozymes that work on a specific glycoprotein. This is the void current study is intended to fill. MUC1, MUC4 and MUC16 (also called CA125) are the most widely studied membrane-bound mucins (Bafna et al. 2010) . All three mucins have been shown to be decorated with various pancarcinoma antigens including sLe a and sLe x (Fernandez-Rodriguez et al.
2001
; Croce et al. 2007; Groux-Degroote et al. 2008; Barthel et al. 2009; Remmers et al. 2013) . Although some of the isozymes that participate in the synthesis of these two selectin ligands have been identified, specific isozymes of these four groups of enzymes that synthesize these glycotopes on a given glycoprotein are largely not known. Recently, we showed that β3GalT-I and ST3Gal-VI are involved in the synthesis of sLe a and sLe x on MUC1 in prostate and colon cancer cells, respectively Chachadi et al. 2013) . These studies also show that these two enzymes control the metastatic properties of these two cancer cells in an enzyme, mucin and cancerspecific fashion. Identification of additional glycoprotein-specific glycosyltransferase isozymes that are involved in the synthesis of these two selectin ligands is needed in order to gain a comprehensive understanding of the selectin-mediated cancer metastasis and develop a novel therapy.
In the present study, we have shown that β3GalT-V is involved in the synthesis of MUC16-associated sLe a in H292 cells while FucT-V participates in the synthesis of sLe x associated with MUC1 in CFT1
and H292 cells. Depletion of β3GalT-V or FucT-V in H292 cells results in suppression of their metastatic potential by reducing cell migration, and suppression of tethering to and rolling on immobilized E-and P-selectin under dynamic flow. The results further support the concept that glycosylation of a given glycoprotein is GT isozyme specific. However, this phenomenon may be cell type specific. , MUC1, MUC4 and MUC16 in the lysates of these four cells. β-Actin was used as a loading control. Data shown are a representative of three independent experiments. This figure is available in black and white in print and in color at Glycobiology online.
mucins. As shown in Figure 2D, Figure 4A ). The susceptibility of these glycotopes to mixed glycosidases, which contains neuraminidase, showed the congruence of the chemical nature of these glycotopes with those of the selectin ligands. Same result was obtained for MUC16-associated sLe a in H292 cells ( Figure 4A ).
To confirm the presence of terminal α2,3 sialic acid, the sLe a and sLe x immunoprecipitates were analyzed by Maackia amurensis lectin blotting. Figure 4B clearly shows that sLe a and sLe x from CFT1 and H292 cells contain terminal α2,3 sialic acid, which further confirms the chemical nature of these two glycotopes. Figure 5A ). Moderate-to-high levels of expression of B4GALT1, 2, 4 and 5 were detected in all four cell types ( Figure 5B ). Low-to-moderate expression levels of ST3GAL3, moderateto-high expression levels of ST3GAL4 and no expression of ST3GAL6 were found in all four cell types ( Figure 5C ). Also, low FUT3 expression levels were found in all four cell types and moderate expression levels of FUT4 & 5 were detected in CFT1 and H292 cells but very low expression levels in the other two cell types. Low level of FUT6 expression was found in H292 cells and very low to no expression in the other three cell types ( Figure 5D ). To confirm the western blotting results of the membrane-bound mucins ( Figure 2D ), we measured the mRNA levels of MUC1, 4, 16 and 17 genes. Moderate-to-high levels of MUC1 gene expression were found in all four cell types ( Figure 5E ). of all GTs needed for the synthesis of these two glycotopes in these two cell types. Since the expression levels of B4GALT1, 2, 4 and 5 and ST3GAL3 and 4 genes were adequate for producing the expected glycan structures, they were not considered crucial in determining the differential expression of these two selectin ligands between these two and the other two lung cell types. Therefore, analysis of the differential expression of B3GALT and FUT genes among these cells could help identify specific β3GalT and α1,3/4FucT isozymes involved in the synthesis of MUC-associated sLe a and sLe x . Further, presence of sLe a and absence of sLe x on MUC16 in H292 cells suggested that the differential expression of B3GALT5 could be the key determinant. Also, cell-typespecific differences in the expression of glycoprotein-specific FUT genes suggested that FUT4 and 5 were the candidate genes, because these two genes were expressed in CFT1 and H292 but not the other two cell types. To test these ideas, series of siRNA knockdown experiments were carried out to identify the specific GT isozymes involved in the synthesis of sLe a and sLe Figure 6D ), indicating that FucT-V is involved in the synthesis of MUC1-associated sLe a in this cell type.
Knockdown of either B3GALT5 or FUT5 gene decreases in vitro migratory and metastatic properties of H292 cells
To investigate the functional consequences of the aforementioned molecular findings, in vitro cell migration and cell binding were measured by wound healing and parallel plate flow chamber assays under dynamic flow, respectively. Knockdown of either B3GALT5 or FUT5 mRNA in H292 cells by siRNA treatment suppressed cell migration ( Figure 7A ). The rate of cell migration towards the scratch wound was significantly reduced when compared with that of mock-treated CNT cells (Figure 7B) . The difference still existed even at 48 h post scratch. Since sLe a and sLe x are carbohydrate ligands involved in selectin-mediated (E) Expression profile of MUC1, 4, 16 and 17 genes as measured by qRT-PCR. Gene expression levels were sorted according to ΔΔCt method (see Methods for details), normalized with GAPDH (=100%) in same cell preparation, expressed as mean ± SD and plotted in a log scale (n = 3). Gene encoding β3GalT-V involved in the synthesis of sLe a was expressed at moderate levels in all but CFT1 cells, which expressed this gene at a very low level, while high level of MUC16 gene expression was detected only in H292 cells. Similarly, moderate levels of FUT4 and FUT5 genes were expressed in CFT1 and H292 cells.
hematogenous metastasis of cancer cells (Kannagi et al. 2004 ), we proceeded to examine the effect of knocking down either B3GALT5 or FUT5 mRNA in H292 cells on their in vitro interaction with immobilized P-or E-selectin under dynamic flow. We found that knockdown of B3GALT5 mRNA in H292 cells significantly reduced their tethering to and rolling on immobilized E-and P-selectins. When compared with mock-treated cells, cells treated with B3GALT5 siRNAs showed a reduction in the number of cells tethered to E-selectin by 35.6% and P-selectin by 44.7% ( Figure 7C ), and rolled on E-selectin by 64.2% and P-selectin by 22.1% ( Figure 7D ). Also, when compared with mocktreated cells, cells treated with FUT5 siRNAs exhibited a reduction in the number of cells tethered to E-selectin by 44.9% and P-selectin by 49.6% ( Figure 7C ), and rolled on E-selectin by 47.9% and P-selectin by 48.0% ( Figure 7D ). The results indicate that both β3GalT-V and FucT-V play an important role in selectin-mediated tethering and rolling of H292 cells by participating in the synthesis of sLe a and sLe x in a MUC-specific fashion.
Discussion
Cell surface sialyl Lewis antigens play an important role in selectinmediated leukocyte trafficking (Kawarada et al. 2000; Ugorski and Laskowska 2002) and cancer metastasis (Shimodaira et al. 1997; Dimitroff et al. 2004 ). Synthesis of these two glycotopes requires participation of four groups of GTs, β3GalT, β4GalT, ST3Gal and FucT. Each of these GT gene families contains several isozymes. The involvement of specific isozymes of each GT family in the synthesis of these two selectin ligands in a given glycoprotein is largely unknown. In this study, we have identified β3GalT-V as the isozyme involved in the synthesis of sLe a associated with MUC16 in H292 cells. Also, we have identified FucT-V as the isozyme involved in the synthesis of sLe x associated with MUC1 in CFT1 and H292 cells. Further, we have also discovered that by participating in the synthesis of sLe a and sLe x , β3GalT-V and FucT-V play a critical role in the in vitro migratory and metastatic properties of H292 cells.
Biosynthesis of mucin glycans takes place exclusively in the Golgi apparatus in a template-independent process. The glycan structure is determined primarily by (a) the expression levels of GT genes, (b) the substrate specificity of GTs, (c) the Golgi localization of the isozymes of each GT and (d) the intra-Golgi transport route of the glycoprotein substrates in the Golgi in relationship to the Golgi localization of their cognate GTs. Since most isozymes within a GT gene family have overlapping substrate specificities and can produce same product when their enzymatic activities are measured in vitro, it is not possible to attribute a glycan structure generated on a glycoprotein to a specific isozyme based on the enzyme activity measured in cell homogenate. Therefore, to understand the biological function of a GT isozyme, the glycoprotein substrate that carries the glycotope generated by each isozyme in vivo needs to be identified.
It should be pointed out that only few isozymes within each of these four enzyme groups are involved in the synthesis of glycoproteinassociated sLe a and sLe x . For example, there are five β3GalT isozymes which can synthesize β3Gal structure, but only three, including β3GalT-I, II and V, can generate type-1 lactosamine structure (Hennet et al. 1998; Isshiki et al. 1999; Hennet 2002) . There are seven β4GalT isozymes which can synthesize β4Gal structure, but only four, including β4GalT-I, II, IV and V can produce type-2 lactosamine chain (Amado et al. 1999; Furukawa and Sato 1999) . There are six ST3Gal isozymes which can synthesize N-acetylneuraminic acid (NeuAc) α2,3Gal structure, but only three, including ST3Gal-III, IV and VI, can generate NeuAcα2,3Galβ3/4GlcNAc, the precursors of sLe a and sLe x (Sasaki et al. 1993; Okajima et al. 1999) . Further, among the isozymes within each enzyme family, differences in substrate specificity also exist. For example, the preference of ST3Gal-III for type-1 over type-2 lactosamine acceptor suggests that sialylated type-1 chain is its predominant product (Wen et al. 1992; Kitagawa and Paulson 1993) . Also, ST3Gal-IV and VI prefer type-2 over type-1 lactosamine as their acceptor, which makes synthesis of sialylated type-2 chain their primary function (Rohfritsch et al. 2006; Carvalho et al. 2010 ). There are 10 α3/4FucT isozymes which can synthesize α3/4Fuc structure, but only five, including FucT-III-VII, can make sLe a and sLe x in glycoproteins (de Vries et al.
2001
). Further, there are differences in the specificities toward four different acceptors for these enzymes. FucT-III and V can work on both type-1 and type-2 acceptors, and FucT-III prefers type-1 over type-2 and vice versa for FucT-V. These enzymes can work on their respective lactosamine acceptors with or without sialic acid. However, FucT-VII is only active with α2,3 sialylated type-2 lactosamine acceptor (Shinoda et al. 1998) . Altered tumor-associated carbohydrate antigens have been identified in many solid tumors (Cazet et al. 2010 ). Tissue and tumorspecific expression of GT genes also has been reported (Tsuji 1996) . But, very little is known about the specific GT isozymes that are responsible for the synthesis of these altered glycans. Even much less is known about the glycoproteins that carry these tumor-associated carbohydrate antigens in vivo. As shown in Table I , the glycan synthesis in a given glycoprotein is GT isozyme specific. Recently, our lab has shown that β3GalT-I and ST3Gal-VI are involved in the synthesis of MUC1-associated sLe a in human normal prostatic RWPE-1 cells (Chachadi et al. 2013) and sLe x in human colonic adenocarcinoma HCT15 cells , respectively. In the absence of β3GalT-I, MUC1-associated sLe a was not produced despite expression of high level of B3GALT5 gene in RWPE-1 cells. sLe a was generated only after induction of the expression of B3GALT1 gene by treatment with suberoylanilide hydroxamic acid, a histone deacetylase inhibitor (Chachadi et al. 2013) . Also, sLe x was not detected in HCT15 cells which express very low level of ST3GAL6 but moderate-to-high levels of ST3GAL3, ST3GAL4 and ST3GALT5.
Following treatment with 5-aza-2′-deoxycytidine, a DNA methylase Tethering and rolling were visualized with a phase-contrast microscope at ×40 magnification and videotaped. B3GALT5 or FUT5 siRNA-treated cells show reduced in vitro migration, and selectin-adhesion properties. (*P < 0.05, **P < 0.001 for specific siRNA-treated vs. scrambled siRNA-treated cells). This figure is available in black and white in print and in color at Glycobiology online.
inhibitor, sLe
x was generated following a 754-fold increase in the expression of ST3GAL6 gene. The data support the concept that in vivo, each glycoprotein is glycosylated by its cognate GTs in an isozymespecific fashion. Current study provides further evidence to support the concept that in vivo glycosylation of a given glycoprotein is GT isozyme specific. In this study, we have identified specific isozymes of two GTs which participate in the synthesis of MUC-associated sLe a and sLe x . We have found that β3GalT-V is involved in the synthesis of MUC16-associated sLe a in H292 cells. Further, FucT-V is found to be involved in the syn- has the affinity for sialylated type-1 lactosamine. Further, lack of FucT-V is the likely explanation for the inability of BEAS-2B and A549 cells to generate MUC1-associatedsLe x . The low level of MUC16 gene expression in BEAS-2B, CFT1 and A549 cells may further contribute to the absence of MUC16-associated selectin ligands in these cell types. These predictions remain to be verified. These results clearly show that synthesis of MUC-associated glycans is GT isozyme-specific. However, this phenomenon may be cell type specific because of the following reasons. First, ST3Gal6 is required for synthesis of sLe x associated with MUC1 in HCT15 cells but not H292 cells as shown in current study. Second, β3GalT-1 is involved in the synthesis of MUC1-associated sLe a in normal prostatic RWPE-1 cells (Chachadi et al. 2013) but not H292 cells. In this cell type, we show that β3GalT-V is the isozyme which participates in the synthesis of this selectin ligand on MUC1. To gain more insight into this phenomenon, it is necessary to identify GTs required for the synthesis of MUC1-associated sLe a and sLe x in more cell types. Further, given that Golgi targeting of GTs is altered in aggressive cancer cells, which leads to altered glycosylation (Petrosyan et al. 2014) , it is imperative to compare the results between normal and cancerous cells and between same cancer cells with normal and altered Golgi targeting of GTs to determine if the Golgi targeting of a GT remains the same between the above-mentioned cell pair because differences in mucin substrate specificity of ST3Gal6 and β3GalT-1 in different carcinoma cells may be caused by altered Golgi targeting of GTs.
Another interesting finding of current study is that β3GalT-V and FucT-V play an important role in the in vitro metastatic property of H292 cells because knockdown of either gene reduces the migratory and selectin-mediated adhesion properties of these cells. These enzymes and/or the mucins which they work on may serve as potential targets for developing therapeutic strategy to inhibit the metastatic properties of the primary tumors.
Current work provides an additional insight into our concept that each GT isozyme acts only on a subset of glycoproteins even though they show similar sugar substrate specificity and can produce same carbohydrate structure in vitro. Further, it will be of interest to elucidate the mechanism by which GT isozymes meet up with their glycoprotein substrates in cancer cells in vivo, which may provide an opportunity for developing cancer therapy.
Materials and methods

Materials
Dulbecco's modified Eagle's medium (DMEM), F-12K, penicillinstreptomycin, fetal bovine serum (FBS), bovine serum albumin (BSA) and trypsin/EDTA were procured from Life Technologies Inc. Glycoprotein substrates for B4GALT2, 4 and 5, which exhibit same carbohydrate acceptor specificity and generate same glycan product as B4GALT1, have not been identified. c Glycoprotein substrates for ST3GAL3, which acts on NeuAcα2,3Galβ1,3/4GlcNAc and has higher specificity towards type-1 over type-2 glycans (Weinstein et al. 1982) , have not been identified.
CEA, carcinoembryonic antigen; MCAM, melanoma cell adhesion molecule; ESL, E-selectin ligand; PSGL1, P-selectin glycoprotein ligand-1; GlyCAM-1, glycosylation-dependent cell adhesion molecule 1.
(Grand Island, NY). Bronchial epithelial growth medium (BEGM) was obtained from Lonza (Walkersville, MD). Solutions of SDS-PAGE and protein estimation kit were purchased from Bio-Rad (Hercules, CA). A mixture of prestained protein molecular weight standard marker was from Fermentas (Glen Burnie, MD (Yankaskas et al. 1993 ). CFT1 and BEAS-2B cells were grown in BEGM supplemented with hormones and growth factor while A549 and H292 cells were grown in DMEM high glucose medium supplemented with 10% FBS and antibiotics (50 units/mL penicillin and 50 μg/mL streptomycin) at 37°C under 5% CO 2 and water saturated environment.
Gel electrophoresis and immunoblotting
Cell homogenate proteins (50 µg) were separated on 2% SDS-agarose gel as well as SDS-4% polyacrylamide gels under reducing conditions and transferred to PVDF membranes overnight at 4°C. The blotted membranes were blocked at RT for 1 h with a blocking solution [tris buffered saline (TBS), pH 7.4, 5% nonfat dried milk, 0.1% Tween-20] and incubated at 4°C overnight in a blocking solution containing primary Abs with appropriate dilutions. After washing with TBST, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary Ab for 1 h. Immunoreactive bands were detected by Thermo Scientific SuperSignal West Pico Chemoluminescent substrate reagents and exposed to BioExpress Blue Basic Autorad chemo-luminescence film (Kaysville, UT). Prestained protein ladder was used as the molecular-weight markers. Immunodetected β-actin was used to ensure equal protein loading after separation by SDS-12% polyacrylamide gel electrophoresis.
Fluorescence microscopy
BEAS-2B, CFT1, A549 and H292 were grown overnight on cover slips and fixed in 4% paraformaldehyde/PBS at RT for 30 min (Chachadi et al. 2013 
Flow cytometric analysis
Quantitative and comparative assessment of cell surface sLe a and sLe x were performed by flow cytometry using KM231 (sLe a ) and CSLEX1 (sLe x ) Abs as described Chachadi et al. 2013) . Finally, cells were re-suspended in 500 µL of 0.5% paraformaldehyde and analyzed using a FACS Vantage (Becton Dickson San Jose, CA) equipped with 488 nm argon laser and Cell Quest-pro software. The unstained cells and cells incubated with secondary Ab alone served as negative and antibody controls, respectively.
Immunoprecipitation
For immunoprecipitation assays, cell lysates containing equal amounts of protein (500 μg In situ PLA
In situ PLA was performed in CFT1 and H292 cells to analyze association of sLe a and sLe x with MUC1 and MUC16 according to the previously described protocol with minor modifications (Chachadi et al. 2013) . In brief, cells were grown on cover slip for 48 h and fixed with 4% cold paraformaldehyde/PBS at RT for 30 min, washed thrice with PBS and blocked for 1 h in 3% BSA. Cells were incubated with the indicated Ab pairs ( Figure 2B ) (1 : 50 in PBS with 3% BSA) at 37°C for 1 h and washed thrice (5 min each) with PBST. Oligonucleotideconjugated donkey anti-mouse IgG minus (for sLe a ), donkey antimouse IgM minus (for sLe x ) and donkey anti-rabbit plus (for MUC1 and MUC16) PLA secondary probes were added at appropriate dilutions prepared in PBS with 3% BSA and the cells were incubated in a humidified chamber for 1 h at 37°C. PLA secondary donkey anti-mouse IgM minus probe was prepared using Duolink ® In Situ Probemaker
Minus kit (DUO92010) from Sigma-Aldrich (St. Louis, MO) while other probes were directly purchased. The PLA assay was performed using the Duolink PLA kit (Olink Bioscience cat# LNK-92101-KI01, Uppsala, Sweden) according to manufacturer's instruction. Briefly, connector oligonucleotides were hybridized and circularized by ligation for 30 min at 37°C. After thorough washing, the cells were incubated with DNA polymerase for 100 min at 37°C to produce rolling circle amplification products tagged with a red fluorescence probe. Cells were stained with DAPI for nuclei and images were obtained from EVOS ® FL digital inverted fluorescence microscope and photographed at 60× magnification. PLA signals (red fluorescent spots) were quantified by counting all signals obtained from three different images divided by the number of cells in those three images to obtain average signals/cell.
PNGase F or mixed glycosidase treatments
The MUC1 and MUC16 immunoprecipitates were boiled (100°C) for 10 min in 0.5% SDS and 1% β-mercaptoethanol and then treated with PNGase F (Sigma) (5 U/mg protein) in 50 mM phosphate, pH 7.5 containing 1% NP-40 at 37°C for 16 h. The PNGase F activity was validated using transferrin as previously described were resolved by SDS-PAGE and blotted on to PVDF membrane as described earlier. Then, membranes were blocked with TBS containing 3% BSA (60 min), followed by incubation with 1 µg/mL of biotinconjugated MAA (in TBS containing 1 mM MgCl 2 , 1 mM MnCl 2 and 1 mM CaCl 2 , pH 7.5) for 60 min. The treated membranes were washed with TBS containing 0.05% Tween 20 and then incubated with streptavidin-HRP (Pierce) (1 : 20,000) for 30 min. Finally, the blots were washed (5×) with TBS containing 0.05% Tween 20 and then developed using ECL.
Quantitative gene expression analysis of glycosyltransferases and mucins by qRT-PCR
qRT-PCR analyses of the mRNAs of the genes encoding the GTs involved in the synthesis of sialyl Lewis antigens and genes encoding membrane-bound mucins were performed in BEAS-2B, CFT1, A549 and H292 cell types according to the protocol described previously Chachadi et al. 2013) . The results were expressed as % of the target gene relative to that (100%) of GAPDH and plotted as mean expression ± SD. Primer sequences used for the study can be found in earlier publications (Chachadi et al. , 2013 Radhakrishnan et al. 2011) .
siRNA transient transfection
Pool of 3 siRNAs targeting each of B3GALT5, FUT4 and FUT5, and scrambled siRNA were purchased from Santa Cruz Biotechnology. CFT1 and H292 cells at 50% confluence were transfected for 8 h in OPTI-MEM ® reduced serum medium containing 50 nM siRNAs using Lipofectamine RNAi MAX reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's recommendation. The medium was then replaced with a fresh DMEM medium containing 10% FBS for H292 and BEGM supplemented with hormones and growth factor for CFT1 as mentioned in previous section. After cultured for 72 h, the transfected cells were analyzed for B3GALT5, FUT4 and FUT5 mRNA by qRT-PCR for successful knockdown as mentioned above. Effects of gene knockdown on the expression of sLe a and sLe x were determined by western blotting as described in previous section.
Wound healing assay
A monolayer scratch assay as described previously (Cory 2011 ) was used to compare the migratory ability of H292 cells after knocking down the B3GALT5 or FUT5 gene. Knockdown of B3GALT5 and FUT5 was performed. After 72 h of siRNA treatment, H292 cells were dislodged from T25 culture flasks with a non-enzymatic cell stripper and seeded to six-well tissue culture dishes and grown to confluence. Each confluent monolayer was then wounded linearly using a sterile 200 µL pipette tip and washed three times with PBS. Thereafter, migration was observed and photographed at regular intervals of 0, 12, 24 and 48 h. The distance of cells migrating into the cell-free zone was acquired under a phase contrast microscope and analyzed by ImageJ software. The distances of cell migration were calculated by subtracting the distance between the scratch's edges (wound closure) at indicated time from the distance measured at 0 h.
Parallel plate flow chamber adhesion assay
Recombinant human E-and P-selectins/IgG Fc chimeras were purified and coated to cover slips as described Ali et al. 2012) . The siRNA-treated H292 cells that tethered to and rolled on Eand P-selectin-coated cover slips were measured and compared with mock-treated cells by a parallel plate flow chamber assay as described Chachadi et al. 2011 ) and evaluated according to Krull et al. (1999) . Tethering was determined by counting the number of cells that adhered to slides over the first 2-3 s of continuous shear flow at a given field of view and remained tethered for at least 3 s while rolling was defined as five times cell diameters of forward movement which was assessed at 1.0 dyne/cm 2 . Tethering or rolling was expressed as number of tethered or rolled cells/high-power field during a 10-m observation period. 
Statistical analysis
